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               1. REDUCTION OF CARBONYL COMPOUNDS 
1.1 Alcohol Dehydrogenase 
1.1.1 Introduction 
NAD(P)+-dependent alcohol dehydrogenases ' [ADH; EC 1.1.1.1-2)1'2)  catalyze 
the interconversion of various alcohols and corresponding aldehydes or ketones: 
         RR'CHOH+NAD(P)+ RR'CO+NAD(P)H+H+(1) 
Of numerous ADH, two enzymes from horse liver and from yeast have received much 
attention, and the scrutiny of the former enzyme in particular has greatly contributed 
to the understanding of the reaction mechanism of ADH. 
   The horse liver enzyme (LADH) is a dimer (Fig. 1) of molecular weight of 80,000 
comprised of at least two distinctive subunit types, E and S ("ethanol-active" and 
"steroid-active", respectively).3-6) Most of the studies on LADH have been focused 
on EE isoenzyme, with either purified7-9) or EE predominant preparations, whereas 
some paralleling studies have been performed on SS isoenzyme.9-12) Their primary 
structures are different in the position of six amino acids,13'14) which seems to explain 
the difference in their catalytic properties. It has also been pointed out that the 
replacement of only one of six amino acids by another one results in the appearance 
of "steroid-activity".15) ADH is ordinarily a zinc-metalloenzyme, and LADH con-
tains four zinc atoms per dimer which have been classified into catalytic and non-
catalytic pairs. The catalytic zinc can be specifically depleted with concomitant 
loss of enzymic activity or substituted by other metals with distinctly reconstituted 
activities.16-20) The enzyme is strongly inhibited by metal chelating agents such as 
pyrazole,21-23) and the fact has been well exploited by mechanistic studies.24'25) On 
the other hand, yeast cytoplasmic enyzmes (YADH) are tetramers of molecular 
weight of about 145,000 and ecah subunit contains only "one" catalytic zinc atom.1'26) 
In spite of these differences, the fundamental structures of YADH subunits have been 
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     Fig. 1. Schematic drawing of the ADH-NAD+-DMSO complex with the active site zinc 
               ion. 
considered to be very similar to that of LADH, based on the comparisons of their 
amino acid seugences (Fig. 2).27,28) Although physiological roles of mamalian en-
zymes are still not clear, "steroid-activity" may be of intrinsic importance29,30) rather 
than the activity toward ethanol, because the latter is not a normal bodily constitu-
ent.31) Yeast enzymes can be said32) to participate in either fermentation (Type 
I)33) or ethanol oxidation (Type II).34) 
  1.1.2 Molecular Structure and Substrate Binding 
   Extensive X-ray crystallographic studies have been made on LADH, including 
apoenzyme,35-37) apoenzyme-coenzyme (or its analog) binary complexes,38-40) com- 
plexes with various inhibitors,modified enzymes,42'43,is)and a variety of ternary 
complexes.44-48) 
   As shown in Fig. 1, each subunit of LADH is divided into two domains,36) i.e., 
the coenzyme binding domain and the catalytic domain. These domains are sepa-
rated by a deep active site cleft. The coenzyme binding domain is composed of 
residues 176-318 (See Fig. 2), and has the folding structure of essentially the same 
feature as found in many other NAD+-dependent dehydrogenases.49) The catalytic 
domain is organized by residues 1-175 and 319-374. Two zinc atoms of the sub-
unit bind to this domain. The catalytic zinc atom, which was firstly identified from 
the affinity to an inhibitor, 1,1 0-phenanthroline, and has been repeatedly confirmed 
by the affinity to several substrates and its analogs, is situated at the bottom of a 
deep pocket between the two domains, constructing a hydrophilic center in a strongly 
hydrophobic environment. The zinc atom is ligated by two sulfur atoms from Cys-
46 and Cys-174 and one nitrogen atom from His-67. Selective modifications of Cys-
4650-54,42) or Cys-17455'56) lead to a significant loss of the enzymic activity. The 
forth ligand in the apoenzyme is water or a hydroxide ion, depending on the pH. 
The environment of the active site zinc was discussed in comparison with those in 
other zinc-metalloenzymes.57) In contrast to the catalytic zinc, the structural zinc 
atom is inert for substrate bindnig, because it is firmly ligated by four sulfur atoms 
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     Fig. 2. Amino acid sequences for horse liver and yeast ADH's. A; Ala, C; Cys, D; 
           Asp, E; Glu, F; Phe, G; Gly, H; His, I; Ile, K; Lys, L; Leu, M; Met, N; Asn, 
           P; Pro, Q; Gln, R; Arg, S; Ser, T; Thr, V; Val, W; Trp, Y; Tyr, X; uniden-
            tified. 
from Cys-97, Cys-100, Cys-103, and Cys-111. 
   The catalytic domain in dimeric LADH undergo distinct conformational changes 
upon the formation of a ternary complex, whereas the other parts of the enzyme 
including the coenzyme binding domains, active site clefts, and the main subunit 
interaction area remain virtually unchanged in their conformations. The total change 
is described as a rotation of the catalytic domains with respect to the central core. 
The front and rear parts move about 6-7 A. The rotation, the pith of which con-
sists in the movement of several loop residues such as 53-57 and 295-298, in com- 
bination with coenzyme and substrate bindings, makes the active sites shielded from 
the solvent. The nicotinamide-ring of the coenzyme is positioned close to the active 
site zinc. In an inactive ternary complex with NADH and DMSO, the inhibitor 
dimethylsulfoxide was found to be the fourth ligand of the catalytic zinc directly 
bound through its oxygen and displacing the water molecule in the apeoonzyme 
(Fig. 1).47 48) 
   There have been much debate on the model of substrate binding, particularly 
in relation to the role of the catalytic zinc. Some mechanisms that assume an in-
termediate pentacoordinate zinc57-60) as well as those with the possible formation of 
an outer sphere complex61'62) instead of inner sphere ligation have caused vigorous 
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discussions. Recent crystallographic studies on several ternary complexes, however, 
strongly support the direct binding of the substrate to the catalytic zinc in tetraco-
ordinate fashion. 
    The X-ray diffraction studies on crystals from an equilibrium mixture contain-
ing predominantly NAD+ and p-bromobenzyl alcohol clearly demonstrated the direct 
coordination of the true substrate to the catalytic zinc during the normal reaction 
with LADH. These crystals have been reported to be catalytically active,63) indicat-
ing that the ternary complexes investigated are productive ones. Further evidences 
that are consistent with the fact are as follows: 1) trans-4(N,N-dimethylamino)cin-
namaldehyde (DACA) is known to react with LADH-NADH complex to form a 
transient intermediate with a characteristic absorption spectrum during the course of 
the reduction of this substrate.64,65) The spectrum is very similar to those of model 
complexes between DACA and Lewis acids such as Zn(NO3) 2.66) The complex of 
LADH with 1,4,5,6-tetrahydronicotinamide adenine nucleotide (H2NADH) and 
DACA,67) which also exerts an absorption spectrum analogous to that of the transient 
intermediate described above, has been revealed by the X-ray analysis48) to have a 
zinc-oxygen bond between DACA and the catalytic zinc. 2) An inhibitor, tri-
fluoroethanol, which seems to be an inhibitor only because of the strong binding to 
the enzyme with biased equiliblium against the formation of an aldehyde (both owing 
to the electron-withdrawing substituent), has also been found to ligate directly on the 
catalytic zinc in good agreement with a productive binding mode.45) 3) The analy-
sis of resonance-enhanced Raman spectra68,69) of an intermediate ternary complex 
of LADH with NAD+ and p-(dimethylamino)benzaldehyde (DABA) also supports a 
direct binding mode to the aldehydic substrate. 
   Now, a schematic drawing for the productive substrate binding proposed by 
Branden and Eklund2) seems to be reliable. The zinc-bound oxygen of an alcohol 
can make a hydrogen bond with the hydroxyl group of Ser-48 to release a proton 
into the solvent through a relay system composed of the 2'-hydroxyl group of NAD+-
ribose and the imidazolyl group of His-51.44) The Ser-48 is an almost exclusive 
candidate responsible for proton transfer from (or to) the substrate during the enzymic 
oxidoreduction by LADH. 
1.1.3 Mechanism for Catalysis 
   Starting from the pioneering works by Theorell and his co-workers,70,71) pKa 
values for various processes relevant to ADH action have been evaluated by extensive 
studies as summarized in Table 1. These values can be classified into four groups 
as indicated in Table 1. pKa's for the first three groups have usually been attributed 
to the zinc-bound water molecules in the apoenzyme, the enzyme-NAD+ binary 
complex, and the enzyme-NADH binary complex, respectively. The abolishment of 
the pH-dependency for the binding of NAD+ to an imidazole-bound enzyme70) which 
has no zinc-bound water41) strongly support the attribution. Since similar pKa 
values have been obtained for a water molecule on the zinc atom in several model 
zinc complexes,90) there is no chemical problem for the values themselves in the rather 
large deviation from the value of 15.7 for free water molecule. Furthermore, the 
pKa differences between these three groups are reasonable from the viewpoint of the 
(110)
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                               Table 1. Optimum pKa Value for ADH Reactions
    GrouppKaObservationRef. 
 I9.0-9.6 Rate for binding of NAD+72 
              9.5 Rates for binding of  NAD+ and NADH73 
              9.2 Rates for binding of NAD+ and NADH74 
           9.2 Rate for binding of anion75
           9.2 Rate for binding of anion76 
            9.2 Rate for binding of pyrazole77 
               8.1 Rate for binding of o-phenanthroline73 
                     9.2 Rate for binding of o-phenanthroline (reevaluation) 78 
               9.2 Rate for binding of 2,2'-bipyridine78 
                   9.8 Quenching of protein fluorescence with apoenzyme 79 
                    10.4 Rates for bindings of NAD+ and NADH Distinct from Zn(OH)2 80 
II18.0 Rate for E-NAD+ dissociation72 
            8.0 Rate for E-NAD+ dissociation73 
                  7.6 Rate for E-NAD+ dissociation (reevaluation)74 
          7.6 dH for binding of NAD+81 
             7.6 Proton release with NAD+ binding82 
                  7.6 Rate for binding of benzyl alcohol to E-NAD+83 
                   7.6 Rate for binding 4f trifluoroethanol to E-NAD+84 
               7.6 Rate for binding of pyrazol to NAD+77 
                  7.6 Quenching of protein fluorescence with E-NAD+79 
III11.2 Rate for binding of DACA to E-NADH80 
         >8.6 Rate bin&ing of NADH81
               >9.9 Rate for reduction of /1-naphthaldehyde85 
>10 Rate for binding of anion to NADH76 
               >9.5 Rate for NADH dissociationfrom E-NADH73 
       IV6.4 Rate for oxidation of ethanol86
                 6.6-7.6 Rate for oxidation of benzyl alcohol85 
               6.4 Rate for oxidation of benzyl alcohol87 
             5.4 Rate for oxidation of CICH2CH2OH84 
             4.5 Rate for oxidation of Cl2CHCH2OH84 
             8.3 Rate for oxidation of CF3CH2OH88 
                      8.4 Rate for oxidation of benzyl alcohol with a modified enzyme 57 
                      6.4 Rate for dissociation of benzyl alcohol from E-NAD+-ROH 83
                      6.6 Rate for dissoication of naphtyl alcohol from E-NAD+-ROH 83 
                   <5.5 Proton release with binding of CF3CH2OH to E-NAD+82
          V8.25 Rate for oxidation of ebnzyl alcohol by YADH89 
                 8.25 Rate for reduction of acetaldehyde by YADH89 
         electrostatic interaction between nicotinamide-ring and the zinc-bound hydroxide 
         ion in an enzyme-NAD+ complex and the oil-charge repulsion in an enzyme-NADH 
         complex. As for the pKa for the quenching of protein fluorescence,79) there has 
         been an argument91-93) against the attribution of the values to zinc-bound water, and 
         the ionization of a tyrosine residue was suggested. The problem is, however, still 
controversia1.94) Further studies might be awaited to clarify the discrepancy. 
            The values in the fourth group in Table 1, which control the rate of alcohol 
          desorption from enzyme-NAD+-alcohol complex and the conversion of ternary com-
         plex toward the oxidation of the alcohol, are attributable to the zinc-bound alcohols. 
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      According to Kvassmann, Pettersson and their co-workers, the pKa value for an 
enzyme-NAD+-alcohol complex is linearly dependent on the pKa of the correspond-
      ing free alcohol with Brc nsted a value of about 0.6, which sustains the attribution. 
         These data can be accounted for in a unified fashion by employing a scheme 
      proposed by Kvassmann and Pettersson (Scheme 1),82) which is a revised presenta-
      tion of a scheme that had been proposedl) based on X-ray crystallographic data and 
      the results from earlier studies.71,82) The order of substrate binding is drawn in 
      Scheme 1 in a sequenced manner following the classical studies8"2,72,95-100) although 
      there must be partial randomness to a varing extent depending on the substate em-
       ployed.100-105) 
         For the oxidation of an alcohol, the first step is the binding of NAD+, then con-
      formational isomerization106-108) takes place to bring about the pKa shift from about 
      9.2 (pK9) to about 7.6 (pK7). The rate of NAD+ binding depends on the protona-
      tion state of an enzyme functional group of pK9 which has been considered as the 
      active site zinc-bound water. The easiness of subsequent binding of an alcoholic sub-
      strate to the enzyme-NAD+ binary complex also prefers the protonated state of the 
      complex. In this respect, the reaction scheme is decisively different from the earlier 
      proposal. Ionization of the enzyme-NAD+ complex is considered as a side reaction 
      as shown in Scheme 1. 
          The alcohol in the resulted enzyme-NAD+-alcohol complex is in a proton dis-
      sociation equiliblium at around the pKa of about 6 (pK6) with its alcoholate form 
      prior to the hydride-equivalent transfer step. The postulation of a separate proton 
E, 
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   transfer step distinct from that of hydride-equivalent transfer is highly likely consider-
   ing the substituent effects on  pK6. This regulates both desorption of alcohol and 
   conversion of ternary complex. The independency of proton and hydride-equivalent 
   transfer steps has also been substantiated by detailed inspection of solvent isotope 
   effects on the LADH reaction.25) Under a single turnover condition,24) LADH-
   catalyzed reduction of aromatic aldehydes has been found to be biphasic. The 
   rapid transient phase correpsonds to the process of ternary complex interconversion, 
   i.e., of hydride-equivalent transfer. The deuterium solvent isotope effect25) for the 
   rapid phase during the reduction of aromatic aldehydes was proved to be 1.0+0.1, 
   independent of pH. For the slow transient, on the other hand, inverse isotope ef-
   fects of 2-3 were obtained at high pH's with a decreased value of 0.87 at pH 6.0. 
   The rate of slow transient phase was determined by that of alcohol desorption from 
   the ternary complex. These data are evidently consistent with the uncoupled transfer 
   of proton from the hydride-equivalent transfer and rule out a concerted mechanism 
   for hydrogen transfer previously proposed109-111) to explain comparatively samll p 
values109-113) obtained for LADH- and YADH-catalyzed reactions (Table 2). Solvent 
   isotope effects in YADH catalyzed, reaction also led Klinman and her co-workers to a 
   conclusion to oppose any concerted mechanisms for hydrogen transfer.114'115> 
       Further experimental resultsu6) that are inconsistent with a mechanism involv-
   ing a general acid-base catalysis have been reported for the reduction of DACA (cf. 
   1.1.2) by LADH and NDAH. The rate of appearance of the characteristic absorp-
   tion from an intermediate was pH-independent, whereas the rate for its disappearace 
   depended on pH. That is, the rate of the process decreased largely with the increase 
   in pH, and primary kinetic isotope effects (2.8 at pH 4.33) decreased to the abolition 
   (1.0) above pH 7. The fact can be easily explained provided one assumes a proton 
   transfer step subsequent to hydride-equivalent transfer in the process. Detailed 
   analysis on primary kinetic isotope effects in YADH-catalyzedreaction at various pH 
   also suports a stepwise mechanism.117) 
       As for the molecular mechanism for proton transfer, a scheme based on the X-
   ray structure44l together with supporting evidences from chemical modifications118) 
   has been proposed (Scheme 2). As already mentioned in 1.1.2, the proton transfer 
   system involving His-51, 2'-hydroxyl group of NAD+-ribose, and Ser-48 has been 
                        Table 2. Summary of p value for ADH reactions 
   Reactionp Ref. 
         Oxidation of p-substituted benzyl alcohol by LADHp = —0.76 109 
      Oxidation of 2-substituted ethanolp*= —1.8 110 
       Oxidation of p-substituted benzyl alcoholp+= —0.2 57 
       Reduction of p-substituted benzaldehydep+= +1.1 57
       Reduction of p-substituted benzaldehydep = +2.2 111 
by YADHp+= -f-2.1 112 
       Association Constant with p-substitutedp = -0.85 111 
                          benzaldehydep+= —0.92 112
         Equiliblium conversion of p-substituted 
          benzaldehyde to the corresponding alcoholp = 1.5 111 
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proposed. Carefully designed chemical modifications of LADH such as the treat-
ment with diethyl pyrocarbonate after acetimidylation of all accessible lysin residues 
revealed the existence of at least one essential histidine residue, probably His-51. 
From the pH-dependency of the inactivation of apoenzyme, an unusually high and 
significant pKa value of 9.6 was obtained, and the value was interpreted as identical 
to pK9 of the zinc-bound water in the proton relay system. The possible involvement 
of plural protons in the proton relay system in LADH was also suggested by proton 
inventory experiments.119) 
   The next step in the LADH reaction is the conversion of ternary complex by 
hydride-equivalent transfer from the zinc-alcoholate to NAD+ (See 1.1.4), followed 
by the desorption of the resulted aldehyde. In the next and the last setp, dissocia-
tion of NADH, which is usually the rate-determining step in LADH reaction, com-
pletes the forward reaction. 
   The pH-independency of several processes in LADH action within a usual pH 
range including the NADH dissociation,73) the rapid transient phase in aldehyde 
reduction,85) etc. is explainable without any difficulties as a result of pKa perturba-
tion of zinc-bound water to a rather high value of 11.2 (pKii) in enzyme-NADH 
( 114)
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         complex. 
            The asymmetric pH-dependency in LADH-catalyzed oxido-reduction is probably 
        originated from the difference between zinc-bound alochol-alcoholate equiliblium 
 (pK6) in enzyme-NAD+-alcohol complex and zinc-bound water-hydroxide equilibrium 
(pKii) in enzyme-NADH complex. Contrary to LADH-catalyzed oxidoreduction, 
        apparent symmetry of pH-dependency in YADH-catalyzed reaction (the group V in 
        Table 1) has been reported,89) which is compatible with the existence of a single func-
        tional group to regulate both oxidation and reduction. More detilaed studies with 
        varing substrates are, however, required to corroborate the hypothesis. The apparent 
        symmetry might be accidental coincidence between "pK6" and "pKii", which seems 
        not so surprising considering the metabolic role of YADH (Type I). YADH solely 
        engages in the reduction of acetaldehyde as a result of the adaptative evolution. 
        For the purpose, a high "pK6" value seems much advantageous.
            After all; the chemical nature of ADH reaction might be safely explained as an 
        electrophilic catalysis by the Lewis acid,113) the active site zinc, through the forma-
        tion of zinc-alcoholate bond, which reminds us of essential similatities of the enzymic 
        reaction to Meerwein-Pondorfl-Verley reduction and its reverse Oppenauer oxidation. 
        1.1.4 Mechanism of Hydride Transfer 
            The mechanism for (net) hydride transfer from and to dihydronicotinamides 
        including NAD+-NADH, NADP+-NADPH, and their analogs in enzymic and mimetic 
        reaction systems has been in continuing controversy. Since the pioneering works by 
         Westheimer and his co-workers,120,121) a direct transfer of a hydride in "one-step" 
        had been believed widely over a couple of decades. Later, in 1971, Steffens and 
        Chipman questioned the mechanism based on their results from kinetics.122) Re-
        investigation of Westheimer's reaction system by means of ESR spectroscopy as well 
        as detailed anlayses on the reaction products128,124) also supported the Stefens and 
        Chipman's proposal that the reduction is composed of multi-steps and the transfer 
        of one electron from the dihydronicotinamide-ring to a substrate initiates the total 
        reduction. Since then the mechanism of this (net) hydride transfer reaction has 
         been a subject of large discussion.125-129) 
            The (net) hydride transfer may be explained by three different processes shown 
        in Eq. 2, where PH and S represent a dihydropyridine derivative and a substrate, 
         respectively. 
. e--transferH+-transfer 




H+ (from the solvent) 
                                                  SH2 
            The mechanism of reduction has been investigated extensively with mimetic 
        systems. Since detailed discussion on this topic will appear in elsewhere, we will 
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focus the topic on enzymic systems and evidence obtained so far will be described 
only briefly. 
    Already in 1957, it was reported that ternary complexes including ethanol-NAD+-
ADH, acetaldehyde-NADH-ADH, and other biological systems exert ESR signals 
that may indicate the presence of charge-transfer complexes as intermediates of the 
enzymic reactions.133) However, the signals were so complicated that they could 
not be attributed to any particular species. 
    Substituent effects as well as large kinetic isotope effects associated with the re-
ductions of substituted and unsubstituted benzaldehydes or with the oxidations of 
substituted and unsubstituted benzyl alcohols with a YADH system, on the other 
hand, led Klinman to conclude that the reaction does not involve the intermediate. 
111,112,114) Few years later, however, Klinman and her co-workers studied a-sec-
ondary kinetic isotope effect of the same reduction and concluded that the reaction 
passes through a radical intermediate.115) 
    In the reduction of pyruvate to lactate, isoenzymes of lactate dehydrogenase 
from pig heart and pig muscle exerted no kinetic deuterium isotope effect.134) The 
results reveal that the process involving the movement of hydrogen nucleus does not 
constitute the rate-determining step. Here, the isomerization of substrate-NADH 
enzyme ternary complex to an "active complex" is suggested to be the rate-determin-
ing step. A question whether the "active complex" corresponds to a "charge-transfer 
complex" or to a "conformationally distorted complex" remains unsolved. 
    Theoretical considerations on kinetic isotope effects for the reduction with ADH 
suggests that there is little charge on the carbonyl carbon of the substrate.135) The 
out-of-plane bending of C4-H in the dihydropyridine-ring and tunneling effect con-
tribute largely to the large kinetic isotope effect.135-137) 
    Thus, scattered results prevent us from obtaining an unequivocal conclusion on 
the mechanism of enzymic (net) hydride transfer process. 
    In addition to pysical organic techniques mentioned above, product analyses 
have been done from the viewpoint to diagnose the reaction mechanism. Namely, 
the reaction with LADH was investigated by means of several chemically based 
radical probes such as nortricyclanone, 2,2-dimethyl-5-hexenal, and cis-3-phenyl-
propenal.138) These substrates did not afford the rearranged products indicating 
that there is no radical intermediacy in the reaction. Similar result was obtained 
in LADH oxidation of a-hydroxyalkylcyclopropanes.139) It is known that cyclopro-
pylmethyl free radical isomerizes into butenyl free radical quantitatively,140) but the 
whole product from the enzymic reduction reserved the cyclopropyl moiety. 
    Despite the results that support the one-step mechanism, the multi-step mecha-
nism cannot be discarded at present, because the entropically frozen system such as 
a reaction in an active site of enzyme is easily expected to afford the unisomerized 
product. It is not surprising in organic reaction system that an in-cage reaction 
results in the product unaffected by enveronmental conditions. 
    Thus, both for enzymic and mimetic reactions, discussions on the mechanism of 
(net) hydride transfer will be continued further. In this review, we will denote the 
transferring species as a "hydride-equivalent". 
(116)
                               Pyridine Nucleotide-Dependent Enzymes 
     1.2 Lactate Dehydrogenase 
      1.2.1 Introduction 
         NAD+-dependent L-lactate dehydrogenase [LDH; EC  1.1.1.2  7]141) catalyzes the 
      reversible oxidation of L-lactate to pyruvate: 
CH3CH(OH)COOH+NAD+ CH3C000OH+NADH+H+ (3) 
      LDH from various sources are usually tetramers of molecular weight of about 140,000. 
     In higher animals, there are A (M; muscle type), B (H; heart muscle type), and C 
      (X; testis type) subunits. It is known that these subunits are encoded by separate 
      genes (Fig. 3),142-144) and isoenzymes composed of these subunits are distinguishable 
      each other by electrophoresis,115,146) immunochemical methods,147-151) chemical com-
      position,142-154) and kinetic properties.154,155) Affinity chromatography and ion ex-
      change chromatography are useful for isolation of each isoenzyme in practical scale. 
      150,156-159) In somatic tissues, LDH exists as isoenzymes composed of nonrandom 
combinations160) of A and B subunits to form tissue-specific isoenzyme pattern, al-
     though random (statistical)  combinations have been demonstrated in vitro.161) A 
     time lag in the protein synthesis for each subunit might be an important factor for 
      the results. The A/B ratio differs from tissue to tissue.150,162-164) It also differs, as 
     a result of variable expresison of the genes,162) in the same tissue of an organ at dif-
      feaent developmental stages.165) It has been recognized that comparatively anaerobic 
     tissues such as skeletal muscle and liver prefer B type which is more adequate for 
     pyruvate reduction than A type, and vice versa.166) The C type of LDH has been 
      found uniquely in mature testes and spermatozoa.156,167) and is known to localize in 
      the mitochondria.167) In mouse, rabbit, human, ram, and dog, only the C4 isoen-
     zyme has been detected, whereas multiple forms of LDH C have been reported in 
     rat, bull, pig, pigeon, etc.156) LDH C is more sensitive to pyruvate inhibition than 
     the lactate inhibition. Thus, LDH C might play an important role for the oxidation 
     of lactate in vivo. Although the physiological role of the C type LDH is still obscure, 
     one proposal has been that the C4 isoenzyme participates in a transmitochondrial 
      oxidation-reduction shuttle.167) These animal enzymes do not exhibit cooperativity 
      in the coenzyme binding, whereas some allosteric activation by anions such as chlo-
      ride168) and phosphate169) has been reported. Usually LDH from bacterial sources 
      are allosterically activated by a large "anion", fructose-1,6-bisphosphate,170-177) and 
      these in particular are called conventionally as allosteric LDH's. The complete se-
     quence of an allosteric LDH from L. casei has been determined and a considerable 
     homology of about 37% (and of 70% within the active site) to verteblate LDH has 
     been documented.172) LDH is not a metalloenzyme in contrast to ADH.151) It is 
     suspected that LDH does not require the metal ion-catalysis because the substrate 
     for this enzyme is much more reactive toward the reaction than those for ADH. 
     1.2.2 Molecular Structure and Substrate Binding 
         Crystallographic studies of LDH include those on apoenzyme (dogfish muscle 
     A4,178) pig heart B4i179> and mouse C4180)), binary complexes (dogfish A4181-184)), 
      abortive ternary complexes (dogfish A4,185,186) pig A4,187)and pig B4188)), and an 
     active ternary complex (pig B4189)) . 
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                  LQKSATTLWDIQKDLKF - Dogfish Muscle 
IKKSATTLWGIQKELQ F Chicken Muscle 
                 LKKSADTLWGIQKELQ F Pig Muscle
                  LKKSADTLWSIQKDLKDL Chicken Heart
LKNSADTLIVGIQKDLKDL Pig Heart 
                  LKKSADTLWNMQKNLE L Mouse Testis 
                  FKKSCDILWNIQKNLE L Rat Testis 
                              Fig. 3. Amino acid sequencesfor various LDH's. 
          Usually, each LDH subunit is divided into four domains : N-terminal arm, 
      coenzyme binding domain, loop and helix aD region, and substrate binding (cata-
      lytic) domain. N-Terminal arm (residues 1-20) might engage in subunit interac-
       tions across the R-axis in LDH tetramer.141) Bacterial LDH, however, lacks the 
       first 14 residues of the N-terminal arm in vertebrate LDH and yet tetramer,143,172'177) 
      which makes the role of the N-terminal arum unclear. The coenzyme binding 
      domain, the loop region, and the catalytic domain are composed of residues 22-97 
       and 115-164 (a conventional numbering based on the results from earlier sequencing 
      works, which has been widely employed in various reports including those of X-ray 
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       studies)  (21-95 and 118-163; a numbering shown in Fig. 3, which hereafter is given 
       in parentheses), 98-114 (96-117), and 165-331 (164-333), respectively. The coen-
       zyme is placed in the bottom of a cleft with the nicotinamide-ring buried deeply 
       within the subunit.182) Upon the formation of ternary complex, definite conforma-
        tional changes occur in regions around the active center.185,186,189> Consequently, 
       the loop covers the active site pocket and the C-terminal helix aH. At the same 
       time, the unreactive B side of nicotinamide is set in hydrophobic environment com-
      posed of Thr-264 (248,) Ile-250 (252), Val-138 (136), and Leu-167 (165)189) Arg-10l 
       in the loop forms, changing its position by 13 A, an ionic bond with the pyrophosphate 
       moiety of the coenzyme. The movement of the loop not only introduces various 
       charged groups into the vicinity of the substrate binding site, but also is responsible 
       for conformational change of the essential His-195 which moves about 2 A toward 
        the substrate. 
           Solvent molecules in the active site seems to be excluded through a hydrophilic 
       gap between the loop and the rigid part of the molecule, which is lined by Glu-107 
      (104), Arg-109 (106), Glu-194 (192), Asp-197 (195), Asp-231 (233), Asp-234 (236), 
       Tyr-237 (239), Glu-238 (240), and so on.179) Increase in the susceptibility to pro-
       teolysis of an immobilyzed LDH upon the formatoin of productive ternary complex 
       supports the conformational changes.199) ESR studies employing a spin-labeled 
       active analog of NAD+ have provided experimental data that are consistent with a 
       fluctuation of the loop between open (up) and closed (down) forms in solution.191) 
       The rigidly closed loop is a trait of the ternary complex, and at the stage of the binary 
       E-coenzyme complex, an open conformer is still predominant182,191) at least in the 
       case of dogfish A4 and pig B4 isoenzymes. In addition, the primary structure of the 
       loop region of A and B subunits are almost completely conserved, whereas C sub-
       units have a rather different (about 50% conservation between A or B and C sub-
       units) sequence.143) Curiously, the loop in the crystals of apo LDH C4 has been 
       found to have a closed ternary-like conformation. This may be the result of pre-
       ferred crystallization from a fluctuating mixture of open and closed forms in solution, 
       which may partly explain the low turnover number of the C4 isoenzyme (5-10% 
       of that of the somatic LDH) .18o) 
           The structure of the productive ternary complex has been estimated by the 
       analysis of various model complexes. An abortive E-NAD+-pyruvatecomplex, which 
       was firstly investigated in detail, was found to be a binary complex in reality because 
        it contains a covalent bond between NAD+ and pyruvate. The complex is reversibly 
       formed by the reaction of E-NAD+ with the enol form of pyruvate.192-195) The nu-
       cleophilic attack of pyruvate enol occurs stereospecifically at the C4 position from the 
       A side of the nicotinamide-ring (Scheme 3). The significance of this observation 
        upon the mechanism of normal oxidoreduction with LDH is obscure, because the 
        normal reaction requires the keto form.192,196) At the same time, both pyruvate and 
       NAD+ are in oxidized states. The same adduct formation can easilybe accomplished 
        by non-enzymic base catalysis without, of course, any stereospecificity. In the case 
        of the non-enzymic reaction, further bond formation between the amide nitrogen 
        and the pyruvate carbonyl carbon occurs to give a cyclized adduct. The cycliza- 
                                  (119)
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        tion reaction also occurs when the adduct formation is performed in the presence of 
        LDH at a raised pH of 10, probably after the dissociation of the first adduct from 
         the enzyme.193,194) The possible physiolosical significance of the complex formation 
         has been discussed.141,197) 
            A most plausible mode of the productive substrate binding has been deduced. 
        Scheme 4 shows a model built with the true substrate taking into account the elucidat-
        ed structure of active site of an abortive complex as well as the result from chemical 
        modification. The latter evidence indicates the presence of a single histidine198) and 
        several arginine199) reidues essential for the catalytic activity. 
            The carboxyl group in the substrate forms a salt bridge with the guanidinium 
        group of Arg-171. The imidazolyl group of His-195 is in contact with the alcoholic 
        oxygen of the substrate through a hydrogen bond, thus acting not only as an acid-
        base catalyst but also as one of the "three points" in the stereospecific oxidoreduction 
        of the substrate.200) (The formation of an abortive complex may also be catalyzed 
        by His-195.193)) The substrate is placed between His-195 and the C4 position of the 
        nicotinamid-ring. Another arginine residue, Arg-109 shown in Scheme 4, one of 
        the loop residues, is brought into the vicinity of the active site by the large move- 
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(120)
                        Pyridin Nucleotide-Dependent Enzymes 
ment of about 23 A. 
   The estimation has been substantiated by the analysis of an  active "trenary" 
complex  E-S-lacNAD+,189) S-lacNAD+ has a structure in which (S)-lactate is covalent-
ly bound through a methylene spacer in the C5 position of the nicotinamide-ring201) 
and undergoes an intramolecular hydride-equivalent transfer in the presence of pig 
heart LDH to form 5-(2-oxalylethyl)NADH reversibly.202) The elucidated mode of 
substrate binding was proved to resemble closely the earlier proposal. 
   Although considerable interest had been devoted on a possible participation of 
Cys-165 (163) in catalysis,203-205) it is now not clear if an indispensable role is rendered 
to this cystein. X-ray data have indicated that the residue is at least not directly 
involved in LDH action. Furthermore, this cystein is out of the amino acid con- 
servation with an alteration to threonine in the lobster tail206,207) and L. casei172) 
enzymes. These fcats, of course, do not necessarily exclude the "essentiality" of the 
residue(s). However, thiomethylation of Cys-165 in pig B4 LDH208-210) was found 
to retain full catalytic activity of the enzyme (i.e., an equal Vmaz to that of the native 
enzyme), though the affinity of the enzyme for its substrates was markedly decreased 
(about 30 times weaker binding for pyruvate). Some additional steric hindrance 
carried into the active site by chemical modification of Cys-165 might prevent the 
movement of the essential His-195 toward the substrate binding site.210) It is in-
teresting to know if a nonpolar and small amino acid such as alanine can replace 
Cys-165 without abolition of the enzymic activity. 
1.2.3 Mechanism for Catalysis 
   The reaction proceeds through an ordered pathway211-216) with the initial addi-
tion of a substrate followed by the binding of coenzyme. LDH does not form an 
E-lactate nor an E-pyruvate complex in the absence of NAD+ or NADH. In the 
reaction with LDH, chemical processes are so rapid (essentially instantaneous reac- 
            COOH 
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     tions) that an equiliblium between ternary complexes (E-NAD+-lac , — E-NADH-
     pyr) is achieved before the establishment of the steady state. As a result, ka/kD for 
     overall reaction is 1.0.134) The equiliblium constant changes depending on pH or 
      concentration of lactate. There is a conservation of charge during the interconver-
     sion of the ternary complexes. An isomerization of the E-NADH-pyr complex leads 
     to the dissociation of pyruvate, and further isomerization after the dissociation of 
     pyruvate brings about a change of pKa of a group (probably His-195) in the enzyme 
     to release a proton. The rate-determining step in the steady state of NADH forma-
     tion is the step for the dissociation of NADH. 
         Concerning to the mechanism of the reaction with LDH, a modified scheme of 
      "oil-water-histidine" mechanism by Parker and Holbrook271) was presented recently 
     by Grau and his coworkers.189) The scheme takes a reversible domino effect into 
     account in the reaction course. For the oxidation of lactate, NAD+ binds to the 
     enzyme initially to form an open loop binary complex predominantly, then, as al-
     ready mentioned above, lactate binds to this binary complex to form a ternary com-
     plex, which results in the closure of the loop. In this complex, the nicotinamide 
     moiety is forced into a hydrophobic environment, which may destabilize the positive 
     charge on the Ni position of nicotinamide. The oil-charge repulsion might lead to 
     the electron flow to induce a positive charge on the C4 position, which promotes the 
     transfer of (net) hydride. A concomitantly developed charge on His-195 after proton 
     transfer causes charge repulsion against Arg-109, which may lead to the dissociation 
     of the Michaelis complex, pushing the loop to be opened. 
         For the reverse, introduction of Arg-109 into the active site of enzyme may lead 
     to decrease in pKa of the protonated His-195 to facilitate the protonation of the 
     carbonyl group in a substrate forming a (formal) carbocation. After the transfer of 
     a hydride-equivalent, the oil-charge repulsion between the hydrophobic wall and the 
     resulted positive charge on the N1 position of nicotinamide leads to the break down 
     of the complex. 
     1.3 Malate Dehydrogenase 
      1.3.1 Introduction 
         Malate dehydrogenase [MDH; EC 1.1.1.37]218) catalyzes the interconversion of 
      L-malate and oxaloacetate. 
        HO-CHCOOHO=CCOOH 
CH2COOHH-NAD+ oH2COOHH-NADH±H+(4) 
         All eukaryotes have at least two distinct isoenzymes: mitochondrial (m-MDH) 
     and cytoplasmic (soluble or supernatant) (s-MDH) . The both enzymes are dimer 
     219,220) ofmolecular wight of about 70,000 comprised of two identical subunits.221-226) 
     Each subunit is catalytically active as a monomer.227)The enzymes are synthesized 
     in the cytoplasm and m-MDH is translocated into mitochondrial matrices guided by 
     a signal peptide in the precursor,228,229) whereas s-MDH remains in the cytosol. 
     m-MDH is a key enzyme in the citric acid cycle,230,231) and alsoconstructs the malate-
     aspartate shuttle230) in coopearation with s-MDH. 
     1.3.2 Molecular Structure and Mechanism for Catalysis 
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            Fig. 4. Schematic representation of the active site in the MDH-NAD+-malate complex. 
         As one of a-hydroxy acid dehydrogenases, MDH is similar to LDH in amino 
      acid sequences,232) X-ray structures,233-236) essential amino acid residues (His237-241) 
      and Arg242,243)), and kinetic properties.244,245) The formation of abortive ternary 
      complex was observed with some MDH.246) Lack of the N-terminal arm which 
     exists in tetrameric LDH and/or the displacement of other amino acid probably 
      makes MDH dimers. Other domain structures including the "loop" region are very 
     similar to those in LDH. These facts may indicate essentially the same molecular 
     mechanism for MDH reaction as estimated for LDH. 
         An estimated structuer of active site236) for enzyme-NADH-oxaloacetate ternary 
     complex is shown in Fig. 4. The 2-carbonyl oxygen interact with the protonated 
imidaoylzl group of an active site histidine by a hydrogen bond as in LDH. The 
      4-carboxyl group contacts with the solvent. 
     1.4 Isocitrate Dehydrogenase
      1.4.1 Introduction 
         There is another group of dehydrogenases that catalyze the decarboxylative de-
     hydrogenation of some /i-hydroxy acids.247) These include isocitrate dehydrogenase 
      [ICDH; EC 1.1.1.41-42],248-251) malic enzyme [ME; EC 1.1.1.38-40],251-258) 6-phos-
      phogluconate dehydrogenase [PGDH; EC 1.1.1.44,259-261) etc.].
         ICDH catalyzes the following reaction. 
          H2CCOO-H2CCOO-
               HCCOO-+NAD+ HCCOO-+NADH+H+ 
HOCHCOO-O=CCOO-
                                          oxalosuccinate 
                                 (a putative intermediate) 
                                           (5) H
2CCOO-
                         CH2+ CO2 +NADH 
O=6coo-
                                2-oxoglutarate 
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 NAD+-dependent ICDH [d-ICDH; EC 1.1.1.41] and NADP+-dependent ICDH [t-
 ICDH; EC 1.1.1.42] have rather different molecular properties each other. Pig 
 heart enzymes have been the most studied ones. The mitochondrial d-ICDH is 
comprised of three dissimilar subunits (a, ~, and y) which occur in the ratio of 2 
:1 :1.247) Each of them has a molecular weight of about 40,000262-264) and exerts a 
  catalytic activity to varing extents.262) The enzyme is allosterically or "apparently" 
  regulated by adenine nucleotides and citrate265-267) as those from various sources.268-271) 
 The activators (Mn2+ and ADP) and the substrates (NAD+ and isocitrate) bind to a 
 half of the subunits (1 site per 2 subunits)272) probably owing to strong negative co- 
 operativity.262,273) On the other hand,the pig heartt-ICDH is a dimer of molecular 
 weight of about 115,000.274,275) The enzyme has been found in both mitochondria 
 and cytoplasm276) and is a non-reguratory enzyme in contrast to d-ICDH. 
     ICDH requires a divalent metal cation.277-283) The metal ion may act not only 
  as a structural part of the substrate-metal ion complex but also as a Lewis acid catalyst 
 for decarboxylation281) as proposed for the non-enzymic metal ion-catalyzed decarboxy-
 lation of p-keto dicarboxylic acids such as oxaloacetate.284,285) Oxaloacetate is a 
 substrate for malic enzyme which also requires a divalent cation.252,255) Interest-
 ingly, PGDH does not require the asisstance of a divalent cation in order to exert the 
 catalytic activity. The fact that PGDH has the substrate-specificity on /-keto mono-
 carboxylic acid, 6-phosphogluconate, instead of 8-keto dicarboxylic acid, seems to be 
 related with its different behavior towards the divalent metal cation from the other 
  two enzymes. 
 1.4.2 Molecular Structure and Mechanism for Catalysis 
     Since the carbonyl group in a /3-keto acid is an efficient electron sink, this acid is 
 far more feasible to undergo decarboxylation than the corresponding /3-hydroxy acid. 
 Therefore, it could reasonably be postulated that dehydrogenation from a /3-hydroxy 
 acid occurs prior to decarboxylation. The hypothesis is consistent with the fact that 
 oxalosuccinate, the putative intermediate, added to a solution of the enzyme is de- 
 carboxylated to a-ketoglutarate regardless the presence or absence of NADPH, but 
 it is also reduced to isocitrate when NADPH is present.249) Although these two ac-
 tivities are inherent properties of ICDH,249,250) oxalosuccinate is not a free inter-
 mediate of the normal overall reaction; during the course of reaction with either 
14C-labeled isocitrate and NADP+ or 14CO2 cold a-ketoglutarate and NADPH, almost 
 no radioactivity was incorporated into the oxalosuccinate.251) These results can be 
 explained either by the tight binding and a short life (consequently a low steady-
 state concentration) of the intermediate or by a concerted mechanism for dehydroge-
 nation and decarboxylation. At any rate, the decarboxylation first leads to the for-
 mation of an enzyme-bound enol, which is subsequently protonated to form the 
 ketoic product, 2-oxoglutarate as shown in Eq. 6. 
        H2CCOO-H2CCOO- H+ H2CCOO-
    HCCOO-HCHCH(6) 
I O=CCOO- CO2 -O-CCOO-O=CCOO-
     Informations on the structure are mostly confined to those from studies with 
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  chemical modification.In particular, glutamyl, (or/and aspartyl), cysteinyl, and 
  lysyl residues are located at or near the substrate binding site, and thus have been 
  implicated in the catalytic action of ICDH. Carboxyl group in the glutamyl residue 
  might be a candidate for the acid-base catalyst in the dehydrogenation step, as sug-
   gested in the ME  reaction.256,286,287) A cysteinyl residue might be involved in the 
   keto-enol tautomerization step as an acid-base catalyst. This residue locates near 
  the C3 of the substrate.288-292) Lysyl residue(s) may participate in the substrate bind-
   ing.293-295) 
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